Cindy Brothers

1.1k total citations
8 papers, 723 citations indexed

About

Cindy Brothers is a scholar working on Infectious Diseases, Virology and Pharmacology. According to data from OpenAlex, Cindy Brothers has authored 8 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Virology and 2 papers in Pharmacology. Recurrent topics in Cindy Brothers's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV-related health complications and treatments (2 papers). Cindy Brothers is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV-related health complications and treatments (2 papers). Cindy Brothers collaborates with scholars based in United States, United Kingdom and Australia. Cindy Brothers's co-authors include Arlene R. Hughes, Sara Hughes, Franco Maggiolo, Jürgen K. Rockstroh, Sherene Min, Patrick Yéni, Benjamin Young, Aza Rakhmanova, José Ramón Arribas and Jan van Lunzen and has published in prestigious journals such as Clinical Infectious Diseases, The Lancet Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Cindy Brothers

7 papers receiving 700 citations

Peers

Countries citing papers authored by Cindy Brothers

Since Specialization

Citations

This map shows the geographic impact of Cindy Brothers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Brothers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Brothers more than expected).

Fields of papers citing papers by Cindy Brothers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Brothers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Brothers. The network helps show where Cindy Brothers may publish in the future.

Co-authorship network of co-authors of Cindy Brothers

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Brothers. A scholar is included among the top collaborators of Cindy Brothers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Brothers. Cindy Brothers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1 2024 ·The Journal of Clinical Pharmacology ·Hardik Chandasana, Ann M. Buchanan, Michael J. McKenna, Cindy Brothers, (unknown), Kimberly K. Adkison, Navin Goyal, Lionel Tan	0
2	Benchmarking the Study Initiation Process 2013 ·Therapeutic Innovation & Regulatory Science ·(unknown), Cindy Brothers, (unknown), Ken Getz	13
3	Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial 2011 ·The Lancet Infectious Diseases ·Jan van Lunzen, Franco Maggiolo, José Ramón Arribas, Aza Rakhmanova, Patrick Yéni, Benjamin Young, Jürgen K. Rockstroh, (unknown), Ivy Song, Cindy Brothers, Sherene Min	226
4	Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Cindy Brothers, Jaime E. Hernández, Amy Cutrell, Lloyd Curtis, Mounir Ait‐Khaled, (unknown), Sara Hughes, Jane Yeo, Didier Lapierre	133
5	High Sensitivity of Human Leukocyte Antigen–B5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients 2008 ·Clinical Infectious Diseases* ·Michael S. Saag, Rukmini Balu, Elizabeth J. Phillips, Philip S. Brachman, Claudia Martorell, William J. Burman, Britt Stancil, Michael Mosteller, Cindy Brothers, Paul Wannamaker, Arlene R. Hughes, Denise Sutherland‐Phillips, S. Mallal, Mark S. Shaefer, (unknown)	290
6	PREDICT‐1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events 2007 ·Pharmaceutical Statistics ·Sara Hughes, Arlene R. Hughes, Cindy Brothers, William Spreen, D. Thorborn	35
7	Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy 2006 ·Drug Safety ·(unknown), Jaime E. Hernández, Cindy Brothers	13
8	Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection 2000 ·Clinical Therapeutics ·Louise Pedneault, Cindy Brothers, (unknown), (unknown), (unknown), Judith Millard, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact